Found 5 matching trials
A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors
PHASE1The purpose of this study is to evaluate the safety of the study drug LY338...
Location
IU Simon Cancer Center
A Study of LY3200882 in Participants With Solid Tumors
PHASE1The main purpose of this study is to evaluate the safety of the study drug ...
Status
Active Not Recruiting
Location
University of Louisville
A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors
PHASE1The main purpose of this study is to evaluate the safety and tolerability o...
Location
Tennessee Oncology PLLC
A Study of Prexasertib (LY2606368), CHK1 Inhibitor, and LY3300054, PD-L1 Inhibitor, in Patients With Advanced Solid Tumors
PHASE1This research study is studying a combination of a targeted therapy and an ...
Location
Dana Farber Cancer Institute
A Study of LY3321367 Alone or With LY3300054 in Participants With Advanced Relapsed/Refractory Solid Tumors
PHASE1The purpose of this study is to evaluate the safety of the study drug known...
Location
The University of Arizona Cancer Center